BioMarin Pharmaceutical Inc. <BMRN.O>: BMO initiates coverage with outperform rating; price target $98
BMRN•Related News
Target lifts annual forecasts again as Fiddelke's turnaround takes root
TGT•
DarioHealth Corp <DRIO.O>: Alliance Global Partners initiates coverage with buy rating; target price $12
DRIO•
Alphabet raises $3.9 billion in inaugural Australian dollar bond
GOOGL•
Quanterix files Form 3 for Chief Commercial Officer James Edward Gute Jr
QTRX•
Mortgage Bankers' Assn. Weekly Applications Survey
SPY•